Atlas FDA

COBAS AMPLIPREP/COBAS AMPLICOR HCV TEST

FDA premarket approval P000012/S017 · decided 2008-08-26

Approval details

PMA number
P000012
Supplement
S017
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
COBAS AMPLIPREP/COBAS AMPLICOR HCV TEST
Generic name
Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
Applicant
Roche Molecular Systems, Inc.
Date received
2007-12-26
Decision date
2008-08-26
Days to decision
244 days
Decision code
APPR
Product code
MZP
Advisory committee
Microbiology
Expedited review
No
Location
Pleasanton, CA
Statement
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ROCHE MOLECULAR SYSTEMS, INC., SOMERVILLE, NEW JERSEY FOR BULK MANUFACTURING AND FILLING OPERATIONS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31